Specifically, higher CCR2 expression in MM cells is correlated with increased bone lesions, and CCR2 chemokines activate mitogen-activated protein kinase (MEK) pathway to support growth of MM cells (92). The gene discussed is MAP2K7; the disease is Miyoshi myopathy.